One pharmacist drew attention to a massive pricing disparity on a key cancer drug, and that disparity may help to explain why ...

(Reuters) -Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for ...

End-of-life care (ELC), or comfort care, describes a robust array of healthcare practices for patients who have stopped ...

Many older adults with advanced cancer receive potentially aggressive treatment but not a lot of supportive care, according ...

Around 21 million adults in the U.S. (8.4%) experienced a major depressive episode in 2023 and Medicare Part B recipients are ...

Researchers analyzed 33,744 fee-for-service Medicare decedents with distant-stage breast, prostate, pancreatic, or lung cancers who died between 2014 and 2019.

Members of the Senate Finance Committee have reintroduced the Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act, a bipartisan bill that would establish a Medicare Coverage pathway to ...

Millions of American women are at high risk for breast cancer, but their insurance does not cover the costs of extra ...

Medicare covers many of the costs of care relating to leukemia. As with other cancers, doctors customize treatment options for people based on their medical history and type of cancer. Original ...

“Even though clinicians and professional healthcare organizations have recommended early integration of supportive and ...

In addition to the coverage in NSCLC, Signatera is also covered by Medicare for adjuvant and recurrence monitoring in colorectal cancer, muscle-invasive bladder cancer, breast cancer, and ovarian ...

Guardant Health (NYSE:GH) reported fourth-quarter adjusted EPS loss of 62 cents, compared to a loss of 64 cents a year ago, ...